438 related articles for article (PubMed ID: 18844446)
1. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
[TBL] [Abstract][Full Text] [Related]
2. Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.
Fogaça SE; Melo RL; Pimenta DC; Hosoi K; Juliano L; Juliano MA
Biochem J; 2004 Jun; 380(Pt 3):775-81. PubMed ID: 15040788
[TBL] [Abstract][Full Text] [Related]
3. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
[TBL] [Abstract][Full Text] [Related]
4. Human tissue kallikrein S1 subsite recognition of non-natural basic amino acids.
Melo RL; Barbosa Pozzo RC; Pimenta DC; Perissutti E; Caliendo G; Santagada V; Juliano L; Juliano MA
Biochemistry; 2001 May; 40(17):5226-32. PubMed ID: 11318645
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
[TBL] [Abstract][Full Text] [Related]
6. Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing.
Chagas JR; Hirata IY; Juliano MA; Xiong W; Wang C; Chao J; Juliano L; Prado ES
Biochemistry; 1992 Jun; 31(21):4969-74. PubMed ID: 1599922
[TBL] [Abstract][Full Text] [Related]
7. Characterization of kininogenase activity of an acidic proteinase isolated from human kidney.
Gomes RA; Juliano L; Chagas JR; Hial V
Can J Physiol Pharmacol; 1997 Jun; 75(6):757-61. PubMed ID: 9276160
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence resonance energy transfer (FRET) peptides and cycloretro-inverso peptides derived from bradykinin as substrates and inhibitors of prolyl oligopeptidase.
Gorrão SS; Hemerly JP; Lima AR; Melo RL; Szeltner Z; Polgár L; Juliano MA; Juliano L
Peptides; 2007 Nov; 28(11):2146-54. PubMed ID: 17904692
[TBL] [Abstract][Full Text] [Related]
9. Nardilysin cleaves peptides at monobasic sites.
Chow KM; Oakley O; Goodman J; Ma Z; Juliano MA; Juliano L; Hersh LB
Biochemistry; 2003 Feb; 42(7):2239-44. PubMed ID: 12590613
[TBL] [Abstract][Full Text] [Related]
10. Attenuated kinin release from human neutrophil elastase-pretreated kininogens by tissue and plasma kallikreins.
Dulinski R; Suder P; Guevara-Lora I; Rapała-Kozik M; Potempa J; Silberring J; Imamura T; Travis J; Kozik A
Biol Chem; 2003 Jun; 384(6):929-37. PubMed ID: 12887060
[TBL] [Abstract][Full Text] [Related]
11. Defining the substrate specificity of mouse cathepsin P.
Puzer L; Barros NM; Oliveira V; Juliano MA; Lu G; Hassanein M; Juliano L; Mason RW; Carmona AK
Arch Biochem Biophys; 2005 Mar; 435(1):190-6. PubMed ID: 15680921
[TBL] [Abstract][Full Text] [Related]
12. Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.
Pimenta DC; Fogaça SE; Melo RL; Juliano L; Juliano MA
Biochem J; 2003 May; 371(Pt 3):1021-5. PubMed ID: 12578561
[TBL] [Abstract][Full Text] [Related]
13. Substrate specificity studies of the cysteine peptidases falcipain-2 and falcipain-3 from Plasmodium falciparum and demonstration of their kininogenase activity.
Cotrin SS; Gouvêa IE; Melo PM; Bagnaresi P; Assis DM; Araújo MS; Juliano MA; Gazarini ML; Rosenthal PJ; Juliano L; Carmona AK
Mol Biochem Parasitol; 2013 Feb; 187(2):111-6. PubMed ID: 23354130
[TBL] [Abstract][Full Text] [Related]
14. Synthetic peptides and fluorogenic substrates related to the reactive site sequence of Kunitz-type inhibitors isolated from Bauhinia: interaction with human plasma kallikrein.
Oliva ML; Santomauro-Vaz EM; Andrade SA; Juliano MA; Pott VJ; Sampaio MU; Sampaio CA
Biol Chem; 2001 Jan; 382(1):109-13. PubMed ID: 11258660
[TBL] [Abstract][Full Text] [Related]
15. Met-Lys-bradykinin-Ser, the kinin released from human kininogen by human pepsin.
Silva RA; Chagas JR; Juliano L; Hial V
Immunopharmacology; 1996 May; 32(1-3):76-9. PubMed ID: 8796271
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and hydrolysis by cysteine and serine proteases of short internally quenched fluorogenic peptides.
Melo RL; Alves LC; Del Nery E; Juliano L; Juliano MA
Anal Biochem; 2001 Jun; 293(1):71-7. PubMed ID: 11373081
[TBL] [Abstract][Full Text] [Related]
17. Neprilysin carboxydipeptidase specificity studies and improvement in its detection with fluorescence energy transfer peptides.
Barros NM; Campos M; Bersanetti PA; Oliveira V; Juliano MA; Boileau G; Juliano L; Carmona AK
Biol Chem; 2007 Apr; 388(4):447-55. PubMed ID: 17391066
[TBL] [Abstract][Full Text] [Related]
18. Selective neurotensin-derived internally quenched fluorogenic substrates for neurolysin (EC 3.4.24.16): comparison with thimet oligopeptidase (EC 3.4.24.15) and neprilysin (EC 3.4.24.11).
Oliveira V; Campos M; Hemerly JP; Ferro ES; Camargo AC; Juliano MA; Juliano L
Anal Biochem; 2001 May; 292(2):257-65. PubMed ID: 11355859
[TBL] [Abstract][Full Text] [Related]
19. Comparison of human and porcine tissue kallikrein substrate specificities.
Del Nery E; Chagas JR; Juliano MA; Juliano L; Prado ES
Immunopharmacology; 1999 Dec; 45(1-3):151-7. PubMed ID: 10615005
[TBL] [Abstract][Full Text] [Related]
20. Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L.
Desmazes C; Galineau L; Gauthier F; Brömme D; Lalmanach G
Eur J Biochem; 2003 Jan; 270(1):171-8. PubMed ID: 12492488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
